ProQuest Associates IV’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-6,777
| Closed | -$513K | – | 5 |
|
|
2018
Q2 | $513K | Hold |
6,777
| – | – | 0.79% | 5 |
|
|
2018
Q1 | $357K | Hold |
6,777
| – | – | 0.41% | 5 |
|
|
2017
Q4 | $362K | Hold |
6,777
| – | – | 0.48% | 5 |
|
|
2017
Q3 | $404K | Sell |
6,777
-3,645,507
| -100% | -$217M | 0.4% | 5 |
|
|
2017
Q2 | $535K | Hold |
3,652,284
| – | – | 0.68% | 5 |
|
|
2017
Q1 | $303M | Sell |
3,652,284
-299,794
| -8% | -$24.9M | 91.1% | 1 |
|
|
2016
Q4 | $314M | Sell |
3,952,078
-430,686
| -10% | -$34.2M | 88.77% | 1 |
|
|
2016
Q3 | $307M | Sell |
4,382,764
-397,424
| -8% | -$27.8M | 84.52% | 1 |
|
|
2016
Q2 | $185M | Hold |
4,780,188
| – | – | 75.43% | 1 |
|
|
2016
Q1 | $194M | Hold |
4,780,188
| – | – | 75.2% | 1 |
|
|
2015
Q4 | $424M | Hold |
4,780,188
| – | – | 81.8% | 1 |
|
|
2015
Q3 | $354M | Hold |
4,780,188
| – | – | 83.76% | 1 |
|
|
2015
Q2 | $387M | Hold |
4,780,188
| – | – | 79.39% | 1 |
|
|
2015
Q1 | $200M | Buy |
4,780,188
+39,001
| +0.8% | +$1.63M | 65.32% | 1 |
|
|
2014
Q4 | $73.5M | Buy |
+4,741,187
| New | +$73.5M | 37.25% | 2 |
|